SCHEMBL6801686

SCHEMBL6801686

O=C1CCCN1c1cccc(Nc2ncc(Br)cc2[N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
SYK P43405 3/20 0.44
CAMK1D Q8IU85 2/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
RAB9A P51151 2/20 0.43
EGFR P00533 2/20 0.42
NPC1 O15118 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
JAK2 O60674 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3322069 0.78 EGFR (0.54) SYKEGFRL3MBTL1ALDH1A1JAK2
SCHEMBL6803583 0.76 EGFR (0.50) SYKEGFRL3MBTL1JAK2MAPK1
SCHEMBL10138757 0.75 GSK3B (0.56) MEN1KMT2AEGFRL3MBTL1ALDH1A1
SCHEMBL13202019 0.75 KMT2A (0.53) MEN1KMT2AEGFRL3MBTL1CYP1A2
SCHEMBL6798983 0.71 TBK1 (0.50) MEN1KMT2AEGFRL3MBTL1SMN1; SMN2
SCHEMBL6802199 0.70 EGFR (0.48) MEN1KMT2AEGFRNPC1L3MBTL1
SCHEMBL6798773 0.69 MAPT (0.49) MEN1KMT2ARAB9AEGFRNPC1
SCHEMBL3223479 0.69 KMT2A (0.61) GAAMEN1KMT2ARAB9AALDH1A1
SCHEMBL1634757 0.68 ALDH1A1 (0.62) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL29930250 0.68 ALDH1A1 (0.62) GAAMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040081672-A1 Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging GUPTA SHYAM K (US) 2004-04-29 US claimed
US-6723735-B1 TREATMENT OR PREVENTION OF ANXIETY MERCK SHARP & DOHME LTD. 2004-04-20 US disclosed
EP-1214319-B1 IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME (GB) 2003-11-26 EP disclosed
EP-1214319-A1 IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS Merck Sharp & Dohme Limited (GB) 2002-06-19 EP disclosed
WO-2001018000-A1 IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-03-15 WO disclosed